American Association of Individual Investors

Why Tenaya Therapeutics, Inc.’s (TNYA) Stock Is Down 9.02%

As of Monday, May 18, Tenaya Therapeutics, Inc.’s TNYA share price has dipped by 9.02%, which has investors questioning if ...

Analysts Are Bullish on These Healthcare Stocks: Tenaya Therapeutics (TNYA), Context Therapeutics (CNTX)

According to TipRanks.com, Katkhuda is a 5-star analyst with an average return of 31.1% and a 54.0% success rate. Katkhuda covers the Healthcare sector, focusing on stocks such as Mineralys ...

Tenaya Therapeutics Shareholders Approve Expanded Equity Incentive Plan

Detailed price information for Tenaya Therapeutics Inc (TNYA-Q) from The Globe and Mail including charting and trades.

Tenaya Therapeutics, Inc. (TNYA) Reports Q1 Loss, Misses Revenue Estimates

Tenaya Therapeutics (TNYA) delivered earnings and revenue surprises of +4.26% and -97.75%, respectively, for the quarter ...
Insider Monkey

William Blair Analysts Confident on Tenaya Therapeutics (TNYA) Product Pipeline

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) is one of the 10 Best High-Risk Penny Stocks to Buy Right Now. Andy Hsieh of William Blair maintained a Buy rating on Tenaya Therapeutics, Inc. (NASDAQ:TNYA) on ...
Seeking Alpha

Alnylam’s research pact worth up to $1.1B sends Tenaya higher

Tenaya Therapeutics (TNYA) added ~10% in the premarket on Thursday after the company signed a research collaboration with Alnylam Pharmaceuticals (ALNY) to discover cardiovascular drugs in a deal ...
Benzinga.com

Tenaya Therapeutics Stock Jumps After New Alnylam Deal

Tenaya uses human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) with high throughput to identify genetic targets, and human-engineered heart tissue and preclinical in vivo models of ...
Barron's

Tenaya Therapeutics Inc.

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was ...